Definition of Local Recurrence Site in Resected Pancreatic Adenocarcinoma: A Multicenter Study (DOLORES-1).

Kernel density estimation adjuvant chemoradiation pancreatic neoplasms pattern of failure

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
18 Jun 2021
Historique:
received: 05 05 2021
revised: 09 06 2021
accepted: 15 06 2021
entrez: 2 7 2021
pubmed: 3 7 2021
medline: 3 7 2021
Statut: epublish

Résumé

The study aimed to generate a local failure (LF) risk map in resected pancreatic cancer (PC) and validate the results of previous studies, proposing new guidelines for PC postoperative radiotherapy clinical target volume (CTV) delineation. Follow-up computer tomography (CT) of resected PC was retrospectively reviewed by two radiologists identifying LFs and plotting them on a representative patient CT scan. The percentages of LF points randomly extracted based on CTV following the RTOG guidelines and based on the LF database were 70% and 30%, respectively. According to the Kernel density estimation, an LF 3D distribution map was generated and compared with the results of previous studies using a Dice index. Among the 64 resected patients, 59.4% underwent adjuvant treatment. LFs closer to the root of the celiac axis (CA) or the superior mesenteric artery (SMA) were reported in 32.8% and 67.2% cases, respectively. The mean (± standard deviation) distances of LF points to CA and SMA were 21.5 ± 17.9 mm and 21.6 ± 12.1 mm, respectively. The Dice values comparing our iso-level risk maps corresponding to 80% and 90% of the LF probabilistic density and the CTVs-80 and CTVs-90 of previous publications were 0.45-0.53 and 0.58-0.60, respectively. According to the Kernel density approach, a validated LF map was proposed, modeling a new adjuvant CTV based on a PC pattern of failure.

Identifiants

pubmed: 34207481
pii: cancers13123051
doi: 10.3390/cancers13123051
pmc: PMC8234595
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Gastrointest Surg. 2006 Apr;10(4):511-8
pubmed: 16627216
Stat Med. 2018 Mar 30;37(7):1191-1221
pubmed: 29226352
J Clin Oncol. 2008 Jul 20;26(21):3511-6
pubmed: 18640932
Ann Surg. 2006 Aug;244(2):332-3; author reply 333
pubmed: 16858208
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Cancer. 2013 Jun 15;119(12):2350-7
pubmed: 23625519
Cancer. 1976 Mar;37(3):1519-24
pubmed: 1260670
Lancet. 2001 Nov 10;358(9293):1576-85
pubmed: 11716884
Cancer. 1999 Feb 1;85(3):583-90
pubmed: 10091731
Langenbecks Arch Surg. 2012 Aug;397(6):927-32
pubmed: 22382704
Crit Rev Oncol Hematol. 2016 Feb;98:309-24
pubmed: 26653573
Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):901-8
pubmed: 22483737
JAMA. 2007 Jan 17;297(3):267-77
pubmed: 17227978
J Clin Oncol. 2009 Apr 10;27(11):1806-13
pubmed: 19273710
Radiat Oncol. 2016 Oct 19;11(1):138
pubmed: 27756417
Adv Radiat Oncol. 2020 Aug 26;5(6):1197-1205
pubmed: 33305081
Ann Surg. 2007 Nov;246(5):734-40
pubmed: 17968163
Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):911-7
pubmed: 25220717
Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):1007-15
pubmed: 24267969
Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):809-16
pubmed: 21277694
Arch Surg. 1985 Aug;120(8):899-903
pubmed: 4015380
Cancer. 1987 Jun 15;59(12):2006-10
pubmed: 3567862
Cancers (Basel). 2020 Jun 29;12(7):
pubmed: 32610592
BMC Cancer. 2019 Jun 11;19(1):569
pubmed: 31185957
N Engl J Med. 2004 Mar 18;350(12):1200-10
pubmed: 15028824
Cancer. 1990 Jul 1;66(1):56-61
pubmed: 2354408
BMC Med Imaging. 2015 Aug 12;15:29
pubmed: 26263899
Cancer Res. 2014 Jun 1;74(11):2913-21
pubmed: 24840647
Ann Surg. 1999 Dec;230(6):776-82; discussion 782-4
pubmed: 10615932

Auteurs

Alessandra Arcelli (A)

Radiation Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Department of Experimental, Diagnostic and Specialty Medicine-DIMES, Alma Mater Studiorum, Bologna University, 40138 Bologna, Italy.

Federica Bertini (F)

Radiation Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Department of Experimental, Diagnostic and Specialty Medicine-DIMES, Alma Mater Studiorum, Bologna University, 40138 Bologna, Italy.

Silvia Strolin (S)

Medical Physics, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.

Gabriella Macchia (G)

Radiation Oncology Unit, Gemelli Molise Hospital, Università Cattolica del Sacro Cuore, 86100 Campobasso, Italy.

Francesco Deodato (F)

Radiation Oncology Unit, Gemelli Molise Hospital, Università Cattolica del Sacro Cuore, 86100 Campobasso, Italy.
Istituto di Radiologia, Università Cattolica del Sacro Cuore, 00168 Roma, Italy.

Savino Cilla (S)

Medical Physics Unit, Gemelli Molise Hospital, Università Cattolica del Sacro Cuore, 86100 Campobasso, Italy.

Salvatore Parisi (S)

Unit of Radiation Therapy, IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy.

Aldo Sainato (A)

Radiation Oncology, Pisa University Hospital, 56126 Pisa, Italy.

Michele Fiore (M)

Radiation Oncology, Campus Bio-Medico University, 00128 Rome, Italy.

Pietro Gabriele (P)

Radiation Therapy, Candiolo Cancer Institute-FPO, IRCCS Candiolo, 10060 Candiolo, Italy.

Domenico Genovesi (D)

Department of Radiation Oncology, SS. Annunziata Hospital, G. D'Annunzio University of Chieti, 66100 Chieti, Italy.

Francesco Cellini (F)

Istituto di Radiologia, Università Cattolica del Sacro Cuore, 00168 Roma, Italy.
Fondazione Policlinico Universitario A. Gemelli, IRCCS, UOC di Radioterapia, Dipartimento di Scienze Radiologiche, Radioterapiche ed Ematologiche, 00168 Roma, Italy.

Alessandra Guido (A)

Radiation Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.

Silvia Cammelli (S)

Radiation Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Department of Experimental, Diagnostic and Specialty Medicine-DIMES, Alma Mater Studiorum, Bologna University, 40138 Bologna, Italy.

Milly Buwenge (M)

Radiation Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Department of Experimental, Diagnostic and Specialty Medicine-DIMES, Alma Mater Studiorum, Bologna University, 40138 Bologna, Italy.

Emiliano Loi (E)

Medical Physics, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.

Silvia Bisello (S)

Radiation Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Department of Experimental, Diagnostic and Specialty Medicine-DIMES, Alma Mater Studiorum, Bologna University, 40138 Bologna, Italy.

Matteo Renzulli (M)

Radiology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.

Rita Golfieri (R)

Department of Experimental, Diagnostic and Specialty Medicine-DIMES, Alma Mater Studiorum, Bologna University, 40138 Bologna, Italy.
Radiology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.

Alessio G Morganti (AG)

Radiation Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Department of Experimental, Diagnostic and Specialty Medicine-DIMES, Alma Mater Studiorum, Bologna University, 40138 Bologna, Italy.

Lidia Strigari (L)

Medical Physics, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.

Classifications MeSH